← Leaderboards
Christopher Parks
International Aids Vaccine Initiative
$4,922,886
Attributed
$5,937,812
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2009–20$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$18,147,398 · 4
By mechanism
P01$16,117,546 · 3
R01$2,029,852 · 1
Top collaborators
- Ivo C Lorenz5 shared
Most similar at International Aids Vaccine Initiative
Same institution · by research overlap
- Ivo C Lorenz$1,014,926
- Simon Hoffenberg$567,854
- Michael J Caulfield$69,906
- Thomas Hassell$19,768,729
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseDesignVaccinesVectorAntigensProgramsVaccine CandidateVaccinationAnimalsMacaca MulattaResponseVesicular Stomatitis Indiana VirusHiv InfectionsViralVirionOryctolagus CuniculusEpitopesImmunogenicityAnimal ModelParticleAntibodiesNovel VaccinesNeutralizing AntibodyInfection
Grant awards (18)
Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens$2,249,057
P01 · FY2020 · AI · contact PI
Development of novel HIV Env vaccines to augment B lymphocyte responses via delivery of stabilized well-ordered Env spikes for comparative evaluation in preclinical immunogenicity and efficacy studies$14,125
P01 · FY2020 · AI · contact PI
Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens$2,353,868
P01 · FY2019 · AI · contact PI
Development of novel HIV Env vaccines to augment B lymphocyte responses via delivery of stabilized well-ordered Env spikes for comparative evaluation in preclinical immunogenicity and efficacy studies$378,183
P01 · FY2019 · AI · contact PI
Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens$2,635,377
P01 · FY2018 · AI · contact PI
Development of novel HIV Env vaccines to augment B lymphocyte responses via delivery of stabilized well-ordered Env spikes for comparative evaluation in preclinical immunogenicity and efficacy studies$611,410
P01 · FY2018 · AI · contact PI
Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens$2,445,841
P01 · FY2017 · AI · contact PI
Development of novel HIV Env vaccines to augment B lymphocyte responses via delivery of stabilized well-ordered Env spikes for comparative evaluation in preclinical immunogenicity and efficacy studies$736,467
P01 · FY2017 · AI · contact PI
Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens$2,525,443
P01 · FY2016 · AI · contact PI
Development of novel HIV Env vaccines to augment B lymphocyte responses via delivery of stabilized well-ordered Env spikes for comparative evaluation in preclinical immunogenicity and efficacy studies$845,995
P01 · FY2016 · AI · contact PI
Vector Core$346,102
P01 · FY2015 · AI · contact PI
Using VSV Vectors to Display and Evolve Novel HIV Envelope Immunogens$477,940
R01 · FY2013 · AI · contact PI
Vector Core$369,066
P01 · FY2013 · AI · contact PI
Vector Core$606,612
P01 · FY2012 · AI · contact PI
Using VSV Vectors to Display and Evolve Novel HIV Envelope Immunogens$451,019
R01 · FY2012 · AI · contact PI
Using VSV Vectors to Display and Evolve Novel HIV Envelope Immunogens$365,775
R01 · FY2011 · AI · contact PI
Using VSV Vectors to Display and Evolve Novel HIV Envelope Immunogens$380,523
R01 · FY2010 · AI · contact PI
Using VSV Vectors to Display and Evolve Novel HIV Envelope Immunogens$354,595
R01 · FY2009 · AI · contact PI